S100A4
S100A4 (S100 calcium binding protein A4, also known as FSP1, MTS1, CAPL, P9KA, 18A2, PEL98 and 42A) is a member of the S100 family of EF-hand calcium-binding proteins. It regulates cell motility, invasion, differentiation, apoptosis and autophagy. Browse Assay Genie's current range of S100A4 research reagents below, or read on for the biology behind the target.
S100A4 is a calcium-binding protein involved in motility, angiogenesis, cell differentiation, apoptosis and autophagy. Inside the cell, it increases motility and invasiveness by interacting with non-muscle myosin heavy chain IIA (MYH9). It promotes filament depolymerisation and raises the amount of soluble myosin-IIA, which leads to stable protrusions that support chemotaxis. In the nucleus, S100A4 modulates the pro-apoptotic function of TP53. It binds the C-terminal transactivation domain of TP53 and reduces TP53 protein levels.
S100A4 also acts in the extracellular space. There it stimulates T-lymphocytes to produce cytokines, including granulocyte colony-stimulating factor and CCL24. It also stimulates T-lymphocyte chemotaxis as part of a chemoattractant complex with PGLYRP1, which promotes lymphocyte migration through the CCR5 and CXCR3 receptors. This fits its UniProt localisation to the secreted, nuclear and cytoplasmic compartments.
The S100A4 gene belongs to the S100 family, whose members contain two EF-hand calcium-binding motifs. S100 genes include at least 13 members clustered on chromosome 1q21. S100 proteins sit in the cytoplasm and/or nucleus of a wide range of cells and help regulate processes such as cell cycle progression and differentiation. NCBI Gene notes that S100A4 may function in motility, invasion and tubulin polymerisation. It also reports that chromosomal rearrangements and altered expression of the gene have been implicated in tumour metastasis. Multiple alternatively spliced variants encode the same protein. Earlier names include metastasin 1 and calcium placental protein, and the mouse and rat orthologs are both called S100a4.
Altered S100A4 expression and chromosomal rearrangements have been implicated in tumour metastasis, making it a focus for invasion studies.
S100A4 binds non-muscle myosin IIA (MYH9), promoting filament depolymerisation and stable protrusions that support chemotaxis.
S100A4 binds the TP53 C-terminal transactivation domain in the nucleus and reduces TP53 protein levels, modulating its pro-apoptotic function.
Extracellular S100A4 stimulates cytokine production and, with PGLYRP1, drives T-lymphocyte chemotaxis through CCR5 and CXCR3.
S100A4 is a calcium-binding protein that regulates motility, angiogenesis, differentiation, apoptosis and autophagy. It interacts with myosin-IIA (MYH9) to increase cell motility and invasiveness. It also modulates TP53 in the nucleus and stimulates cytokine production and chemotaxis in T-lymphocytes when extracellular.
S100A4 is also called FSP1, MTS1, CAPL, P9KA, 18A2, PEL98 and 42A. Earlier names include metastasin 1 and calcium placental protein. Alternatively spliced variants of the gene have been identified, and all of them encode the same protein.
S100A4 has mouse and rat orthologs, both named S100a4. It belongs to the S100 family clustered at chromosome 1q21. Chromosomal rearrangements and altered expression of the gene have been implicated in tumour metastasis. Check the datasheet of any product for its validated reactivity.
Interaction partners, chemokine receptors and cytokines linked to S100A4 function, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P26447; product specifications from Assay Genie datasheets.